When Will Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Turn A Profit?

By Yahoo! Finance | Jul 20, 2024 at 10:56 AM EST

Citius Pharmaceuticals, Inc. is a late-stage biopharmaceutical company aiming for profitability soon. Analysts project it to break even in 2025 with a 63% annual growth rate. The absence of debt reduces investment risk. For detailed analysis, visit Simply Wall St.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.